Neumora officer plans 41,608-share stock sale

Rhea-AI Filing Summary

Neumora Therapeutics, Inc. (NMRA) reported that officer Aurora Daljit Singh filed a notice of proposed sale of 41,608 shares of common stock of Neumora Therapeutics, Inc. The shares are tied to the exercise of employee stock options and are expected to be disposed of on 08/21/2026 through a broker assisted cashless sale on NASDAQ via Merrill Lynch.

The filing also lists prior sales of Neumora common stock by Aurora Daljit Singh during the past three months on four dates in August 2026, each with specified share counts and total sale prices.

Key Figures

Shares proposed to be sold: 41,608 shares of Common Stock Shares sold on 08/17/2026: 146,706 shares Proceeds on 08/17/2026: $220,135.18 +4 more

7 metrics

Shares proposed to be sold 41,608 shares of Common Stock Proposed sale on 08/21/2026 via broker assisted cashless sale

Shares sold on 08/17/2026 146,706 shares Common Stock sold for total proceeds of $220,135.18

Proceeds on 08/17/2026 $220,135.18 Total consideration for 146,706 shares of Common Stock

Shares sold on 08/18/2026 69,149 shares Common Stock sold for total proceeds of $109,621.88

Proceeds on 08/18/2026 $109,621.88 Total consideration for 69,149 shares of Common Stock

Shares sold on 08/19/2026 61,918 shares Common Stock sold for total proceeds of $101,917.37

Shares sold on 08/20/2026 134,452 shares Common Stock sold for total proceeds of $203,583.59

Key Terms

Rule 144, broker assisted cashless sale, Common Stock, exercise of employee stock options

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

broker assisted cashless sale financial

"Broker assisted cashless sale"

Common Stock financial

"Common Stock | 08/21/2026 | Exercise of employee stock options"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

exercise of employee stock options financial

"08/21/2026 | Exercise of employee stock options"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock sale is being reported for Neumora Therapeutics, Inc. (NMRA)?

The notice reports a proposed sale of 41,608 shares of Neumora Therapeutics, Inc. common stock by officer Aurora Daljit Singh, expected on 08/21/2026 in connection with the exercise of employee stock options via a broker assisted cashless sale.

How will the Neumora (NMRA) shares be sold according to this Form 144?

The 41,608 shares of Neumora common stock are expected to be sold on 08/21/2026 through a broker assisted cashless sale on NASDAQ, with Merrill Lynch identified in the filing as the broker handling the transaction.

Who is selling Neumora Therapeutics (NMRA) shares in this filing?

The selling person is Aurora Daljit Singh, identified as an officer of Neumora Therapeutics, Inc. The filing covers Neumora common stock held for this person’s account, including option-related shares and recent sales reported under Rule 144.

What prior Neumora (NMRA) stock sales are disclosed over the past three months?

The filing lists four prior Neumora common stock sales by Aurora Daljit Singh: 146,706 shares on 08/17/2026 for $220,135.18; 69,149 shares on 08/18/2026 for $109,621.88; 61,918 shares on 08/19/2026 for $101,917.37; and 134,452 shares on 08/20/2026 for $203,583.59.

On which market are the Neumora (NMRA) shares in this Form 144 planned to trade?

The shares covered by the notice are Neumora Therapeutics, Inc. common stock expected to be sold on NASDAQ, with Merrill Lynch identified as the broker for the broker assisted cashless sale scheduled for 08/21/2026.

What type of security is covered in this Neumora (NMRA) Form 144?

The security covered is Common Stock of Neumora Therapeutics, Inc., including shares related to the exercise of employee stock options, with a proposed sale of 41,608 shares and separate disclosure of multiple recent common stock sales.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/21/2026 - 04:34 PM EDT Accepted by SEC EDGAR 08/21/2026 - 04:34 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001793971
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Neumora Therapeutics, Inc.
SEC File Number	001-41802
Address of Issuer	260 ARSENAL PLACE, SUITE 1 WATERTOWN MASSACHUSETTS 02472
Phone	(857) 760-0900
Name of Person for Whose Account the Securities are To Be Sold	Aurora Daljit Singh
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Merrill Lynch 225 Liberty Street Floor 37 New York NY 10281	41608	66379.77	187895912	08/21/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/21/2026	Exercise of employee stock options	Neumora Therapeutics, Inc.			41608	08/21/2026	Broker assisted cashless sale

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Daljit Singh Aurora 260 ARSENAL PLACE, SUITE 1 WATERTOWN MA 02472	Common Stock	08/17/2026	146706	220135.18
Daljit Singh Aurora 260 ARSENAL PLACE SUITE 1 WATERTOWN MA 02472	Common Stock	08/18/2026	69149	109621.88
Daljit Singh Aurora 260 ARSENAL PLACE SUITE 1 WATERTOWN MA 02472	Common Stock	08/19/2026	61918	101917.37
Daljit Singh Aurora 260 ARSENAL PLACE SUITE 1 WATERTOWN MA 02472	Common Stock	08/20/2026	134452	203583.59

144: Remarks and Signature

Remarks
Date of Notice	08/21/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Daljit Singh Aurora
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)